AnaptysBio (ANAB) Stock Chart & Stock Price History $23.32 -0.09 (-0.38%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$23.32 +0.00 (+0.02%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AnaptysBio Stock Price Performance The AnaptysBio (ANAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 1.89%, with a year-to-date return of 76.13%. In the past month, the stock has increased 15.33%, reflecting recent market activity. As of the latest close, AnaptysBio traded at $23.32 with a market cap of $685.14 million and volume of 378,901 shares. Five years ago, the stock traded at $19.01, representing a 22.67% increase over that period. At the time, it had a market cap of $532.51 million and a volume of 302,100 shares. Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.19%1 Month Performance+15.33%3 Month Performance+39.39%Year-To-Date Performance+76.13%1 Year Performance-1.89%5 Year Performance+22.67% ANAB Stock Chart for Monday, June, 16, 2025 ANAB Chart by TradingView AnaptysBio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$23.41$23.32-0.38%$23.71$22.46378,901 shs$685.14 million06/12/2025$23.60$23.41-0.81%$24.22$23.13498,268 shs$687.79 million06/11/2025$23.97$23.60-1.54%$24.37$23.36859,300 shs$693.37 million06/10/2025$23.19$23.97+3.36%$24.29$23.02790,329 shs$704.24 million06/09/2025$23.70$23.19-2.15%$24.41$22.28505,009 shs$681.32 million06/06/2025$21.14$23.70+12.11%$24.01$20.93840,957 shs$696.31 million06/05/2025$21.27$21.14-0.61%$21.32$19.041.18 million shs$621.09 million06/04/2025$23.52$21.27-9.57%$24.68$20.251.97 million shs$624.91 million06/03/2025$21.86$23.52+7.59%$24.16$21.711.01 million shs$691.02 million06/02/2025$22.45$21.86-2.63%$22.82$21.79666,792 shs$642.25 million Get the Latest News and Ratings for ANAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$22.56$22.45-0.49%$22.59$21.50683,007 shs$659.58 million05/29/2025$20.90$22.56+7.94%$22.84$20.50892,851 shs$662.81 million05/28/2025$20.13$20.90+3.83%$22.40$20.631.71 million shs$614.04 million05/27/2025$20.44$20.13-1.52%$20.88$19.92566,607 shs$591.42 million05/26/2025$20.44$20.44$20.75$20.03357,651 shs$600.53 million05/23/2025$20.74$20.44-1.45%$20.75$20.03357,651 shs$600.53 million05/22/2025$20.81$20.74-0.34%$21.33$20.41360,420 shs$609.34 million05/21/2025$21.10$20.81-1.37%$21.31$20.36492,110 shs$611.40 million05/20/2025$20.47$21.10+3.08%$21.63$20.03470,433 shs$619.92 million05/19/2025$20.22$20.47+1.24%$20.73$19.93434,133 shs$601.41 million05/16/2025$20.40$20.22-0.88%$20.73$19.98355,554 shs$594.06 million05/15/2025$19.45$20.40+4.88%$20.79$19.21363,930 shs$599.35 million Related Companies Ascentage Pharma Group International Stock Chart Organon & Co. Stock Chart Apellis Pharmaceuticals Stock Chart Xenon Pharmaceuticals Stock Chart Amneal Pharmaceuticals Stock Chart Mirum Pharmaceuticals Stock Chart Arrowhead Pharmaceuticals Stock Chart NewAmsterdam Pharma Stock Chart Recursion Pharmaceuticals Stock Chart Kiniksa Pharmaceuticals Stock Chart Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANAB) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AnaptysBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANAB Stock Free ANAB Stock Alerts